Company news
Oramed Pharmaceuticals Inc. news in 2025
Oramed Pharmaceuticals Inc.'s news releases, calls and decks from 2025, newest first.
Oramed Reports Fiscal Third Quarter 2025 Financial Results
November 16, 2025
Oramed Pharmaceuticals Inc. declares dividend distribution of common stock purchase rights
November 16, 2025
Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives
October 22, 2025
Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical
April 27, 2025
Oramed Pharmaceuticals Issues Letter to Shareholders
March 3, 2025
Ancillary Agreement Completion Protocol and Supplemental Agreement
February 12, 2025
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin
February 10, 2025